Viridian Therapeutics Inc. (VRDN) Stock Exhibits Volatility Following Pricing of Underwritten Public Offering
Viridian Therapeutics Inc. (VRDN) stock prices were up by 17.96% as of the market closing on September 21st, 2021. This brought the price per share up to USD$12.61 at the end of the trading day. Subsequent premarket fluctuations saw the stock dip by 8.41%, bringing it down to USD$11.55. VRDN Stocks Public Offering September 21st, 2021 saw the biopharmaceutical company announce the pricing of its underwritten public offering. Gross proceeds generated from the offering are expected to be roughly USD$85 million. VRDN stock is selling a total of 6,185,454 shares of its common stock, with each share being priced at